VRAX is under 1.00Came to my attention just under a dollar. Couple of days ago, gave a good buy signal with an Alpha candle. Today is a continuation. Check the stop loss area and adjust the position sizing accordingly.
−3.12 USD
−6.73 M USD
156.42 K USD
4.05 M
About Virax Biolabs Group Limited
Sector
Industry
CEO
James Foster
Website
Headquarters
Lanarkshire
Founded
2013
FIGI
BBG0166WT3L7
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The company was founded by James Foster and Cameron Shaw in 2013 and is headquartered in London, the United Kingdom.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of VRAX is 2.01 USD — it has decreased by −2.43% in the past 24 hours. Watch Virax Biolabs Group Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Virax Biolabs Group Limited stocks are traded under the ticker VRAX.
VRAX stock has fallen by −2.43% compared to the previous week, the month change is a 20.36% rise, over the last year Virax Biolabs Group Limited has showed a −18.62% decrease.
VRAX reached its all-time high on Jul 29, 2022 with the price of 290.00 USD, and its all-time low was 0.60 USD and was reached on May 1, 2024. View more price dynamics on VRAX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
VRAX stock is 5.05% volatile and has beta coefficient of 3.37. Track Virax Biolabs Group Limited stock price on the chart and check out the list of the most volatile stocks — is Virax Biolabs Group Limited there?
Yes, you can track Virax Biolabs Group Limited financials in yearly and quarterly reports right on TradingView.
VRAX net income for the last half-year is −3.82 M USD, while the previous report showed −2.91 M USD of net income which accounts for −31.42% change. Track more Virax Biolabs Group Limited financial stats to get the full picture.
No, VRAX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 9, 2024, the company has 17.00 employees. See our rating of the largest employees — is Virax Biolabs Group Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Virax Biolabs Group Limited EBITDA is −6.00 M USD, and current EBITDA margin is −3.84 K%. See more stats in Virax Biolabs Group Limited financial statements.
Like other stocks, VRAX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Virax Biolabs Group Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Virax Biolabs Group Limited technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Virax Biolabs Group Limited stock shows the sell signal. See more of Virax Biolabs Group Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.